 
Religare Enterprises Limited 
CIN: L74899DL1984PLC146935 
Registered Office: First Floor, Office No. 101, 2E/23, Jhandewalan Extn., New Delhi – 110055                                   Phone No.: +91-11- 4167 9692 
Corporate Office: 2nd Floor, Plot A-3,4 & 5, Club 125, Tower B, Sector -125, Noida – 201301, Uttar Pradesh.                Phone No.: +91-120-635 5040 
www.religare.com / investorservices@religare.com 
 
November 14, 2025 
 
The National Stock Exchange of India Ltd             BSE Limited 
Corporate Communications Department           Department of Corporate Services 
“Exchange Plaza”, 5th Floor,               Phiroze Jeejeebhoy Towers 
Bandra-Kurla Complex, Bandra (East),                     Dalal Street, Mumbai – 400 001 
Mumbai - 400051 
 
Scrip Symbol: RELIGARE                 Scrip Code: 532915 
 
 
Subject: Monitoring Agency Report for the quarter ended September 30, 2025  
 
Dear Sir/ Ma’am,  
  
Pursuant to Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) 
Regulations, 2015 read with Regulation 162A of SEBI (Issue of Capital and Disclosure 
Requirements) Regulations, 2018, please find attached Monitoring Agency Report f or the quarter 
ended September 30, 2025, issued by CARE Ratings Limited, Monitoring Agency, in respect of the 
utilization of proceeds raised through Preferential Issue of convertible warrants by the Company.  
 
This is for information and records. 
 
Thanking You, 
 
Yours faithfully, 
 
For Religare Enterprises Limited 
 
 
 
Anuj Jain 
Company Secretary & Compliance Officer 
 
Encl.: As above 
 
  
 
 CARE Ratings Limited  9th floor, C-001/A2, Berger Towers, Sector 16B, Noida,  Gautam Budh Nagar, Uttar Pradesh -201301  Phone: +91-120-4452000 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-22-6754 3456 Email: care@careedge.in  •  www.careedge.in CIN-L67190MH1993PLC071691  
  
 No. CARE/NRO/GEN/2025-26/1145     Monitoring Agency Report  The Board of Directors Religare Enterprises Limited  1407, 14th floor, Chiranjiv Tower, 43 Nehru Place, New Delhi - 110019 November 14, 2025  Dear Sir/Ma’am,  Monitoring Agency Report for the quarter ended September 30, 2025 - in relation to the Preferential Issue (whichever is applicable) of Religare Enterprises Limited (“the Company”)  We write in our capacity of Monitoring Agency for the Rights Issue for the amount aggregating to Rs. 1,500.00 crore of the Company and refer to our duties cast under Regulation 162A of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations.  In this connection, we are enclosing the Monitoring Agency Report for the quarter ended September 30, 2025 as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated August 08, 2025.  Request you to kindly take the same on records.  Thanking you, Yours faithfully,  Jatin Arora Assistant Director Jatin.arora@careedge.in      

 
 CARE Ratings Limited  9th floor, C-001/A2, Berger Towers, Sector 16B, Noida,  Gautam Budh Nagar, Uttar Pradesh -201301  Phone: +91-120-4452000 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East), Mumbai - 400 022 Phone: +91-22-6754 3456 Email: care@careedge.in  •  www.careedge.in CIN-L67190MH1993PLC071691  
  
 Report of the Monitoring Agency  Name of the issuer: Religare Enterprises Limited For quarter ended: September 30, 2025 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: Not Applicable (b) Range of Deviation: Not Applicable  Declaration:  We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013.     The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity.     We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board.    Signature:  Name and designation of the Authorized Signatory: Jatin Arora Designation of Authorized person/Signing Authority: Assistant Director

 
 CARE Ratings Limited  
9th floor, C-001/A2, Berger Towers, Sector 16B, 
Noida,  Gautam Budh Nagar, Uttar Pradesh -201301  
Phone: +91-120-4452000 
4th Floor, Godrej Coliseum, Somaiya Hospital 
Road, Off Eastern Express Highway, Sion (East), Mumbai - 400 022 
Phone: +91-22-6754 3456 
Email: care@careedge.in  •  www.careedge.in 
CIN-L67190MH1993PLC071691 
 
 
 
1) Issuer Details:  
Name of the issuer :  Religare Enterprises Limited 
Name of the promoter : Burman Group (M B FINMART PRIVATE LIMITED, MILKY INVESTMENT AND TRADING COMPANY, PURAN      
ASSOCIATES PVT LTD and VIC ENTERPRISES PRIVATE LIMITED) 
Industry/sector to which it belongs : Core-Investment Company 
 
2) Issue Details  
Issue Period : September 12, 2025 to March 11, 2027 (18 months from date of allotment)  
Type of issue (public/rights) : Preferential issue of Warrants 
Type of specified securities : Warrants convertible into equity shares 
IPO Grading, if any :  Not Applicable 
Issue size (in crore) :  Rs. 1,500.00 crore  
          
3) Details of the arrangement made to ensure the monitoring of issue proceeds:  
Particulars Reply 
Source of information / 
certifications considered by 
Monitoring Agency for preparation 
of report 
Comments of the 
Monitoring Agency 
Comments of 
the 
Board of 
Directors 
Whether all utilization is as per the disclosures in the Offer 
Document?  Yes 
Chartered Accountant certificate*, Bank 
statement, expense invoice and 
Investment Account Statement 
All the proceeds received till Sep 30, 
2025 from warrant issue, have been 
utilized appropriately for the 
objectives mentioned in the offer 
document. 
Nil 
Whether shareholder approval has been obtained in case of 
material deviations# from expenditures disclosed in the 
Offer Document? 
No Management Certificate There has been no deviation Nil 
Whether the means of finance for the disclosed objects of 
the issue have changed?  No Management Certificate Not Applicable Nil 
Is there any major deviation observed over the earlier 
monitoring agency reports?  Not Applicable Not Applicable This is the first monitoring agency 
report. Nil 
Whether all Government/statutory approvals related to the 
object(s) have been obtained?  Yes Management Certificate Not Applicable Nil 
 
 CARE Ratings Limited  
9th floor, C-001/A2, Berger Towers, Sector 16B, 
Noida,  Gautam Budh Nagar, Uttar Pradesh -201301  
Phone: +91-120-4452000 
4th Floor, Godrej Coliseum, Somaiya Hospital 
Road, Off Eastern Express Highway, Sion (East), Mumbai - 400 022 
Phone: +91-22-6754 3456 
Email: care@careedge.in  •  www.careedge.in 
CIN-L67190MH1993PLC071691 
 
 
 
#Where material deviation may be defined to mean:  
a) Deviation in the objects or purposes for which the funds have been raised  
b) Deviation in the amount of funds actually utilized by more than 10% of the amount projected in the offer documents. 
 
4) Details of objects to be monitored:  
(i) Cost of objects –  
Sr. 
No Item Head 
Source of information / 
certifications 
considered by 
Monitoring Agency for 
preparation of report 
Original cost 
 (as per the Offer 
Document) in Rs. 
Crore 
Revised Cost  
in Rs. Crore 
Comments 
of the 
Monitoring 
Agency 
Comments of the Board of Directors 
Reason for 
cost revision 
Proposed 
financing 
option 
Particulars 
of -firm 
arrangement
s made 
1 
Investment (in the form of 
debt or equity) in Care Health 
Insurance Limited 
Placement Document 600.00 Not applicable NA N.A. N.A. N.A. 
2 
Investment (in the form of 
debt or equity) in Religare 
Broking Limited 
Placement Document 200.00 Not applicable NA N.A. N.A. N.A. 
3 
Investment (in the form of 
debt or equity) in Religare 
Housing Development Finance 
Corporation Limited 
Placement Document 250.00 Not applicable NA N.A. N.A. N.A. 
4 Repayment of borrowings 
utilized and availed by the Placement Document 75.00 Not applicable NA N.A. N.A. N.A. 
Particulars Reply 
Source of information / 
certifications considered by 
Monitoring Agency for preparation 
of report 
Comments of the 
Monitoring Agency 
Comments of 
the 
Board of 
Directors 
Whether all arrangements pertaining to technical 
assistance/collaboration are in operation? Not Applicable Not Applicable Not Applicable Nil 
Are there any favorable/unfavorable events affecting the 
viability of these object(s)? No Management Certificate No comments Nil 
Is there any other relevant information that may materially 
affect the decision making of the investors? Yes Stock Exchange disclosure(s) by company The company has reported loss of 
Rs. 6.15 crore in Q1FY2026. Nil 
 
 CARE Ratings Limited  
9th floor, C-001/A2, Berger Towers, Sector 16B, 
Noida,  Gautam Budh Nagar, Uttar Pradesh -201301  
Phone: +91-120-4452000 
4th Floor, Godrej Coliseum, Somaiya Hospital 
Road, Off Eastern Express Highway, Sion (East), Mumbai - 400 022 
Phone: +91-22-6754 3456 
Email: care@careedge.in  •  www.careedge.in 
CIN-L67190MH1993PLC071691 
 
 
Sr. 
No Item Head 
Source of information / 
certifications 
considered by 
Monitoring Agency for 
preparation of report 
Original cost 
 (as per the Offer 
Document) in Rs. 
Crore 
Revised Cost  
in Rs. Crore 
Comments 
of the 
Monitoring 
Agency 
Comments of the Board of Directors 
Reason for 
cost revision 
Proposed 
financing 
option 
Particulars 
of -firm 
arrangement
s made 
Company , together with 
interest payments accrued 
thereon 
5 General Corporate Purpose* Placement Document 375.00* Not applicable NA N.A. N.A. N.A. 
Total 1,500.00  
* Includes, meeting ongoing general corporate exigencies and contingencies, expenses of the Company as applicable in such a manner and proportion as may be decided 
by the Board from time to time, and/or any other general purposes as may be permissible under applicable laws. 
  
 
 CARE Ratings Limited  
9th floor, C-001/A2, Berger Towers, Sector 16B, 
Noida,  Gautam Budh Nagar, Uttar Pradesh -201301  
Phone: +91-120-4452000 
4th Floor, Godrej Coliseum, Somaiya Hospital 
Road, Off Eastern Express Highway, Sion (East), Mumbai - 400 022 
Phone: +91-22-6754 3456 
Email: care@careedge.in  •  www.careedge.in 
CIN-L67190MH1993PLC071691 
 
 
 
(ii) Progress in the objects –  
Sr. 
No 
Item 
Head 
Source of 
information / 
certifications 
considered by 
Monitoring 
Agency for 
preparation of 
report 
Amount as 
proposed 
in the Offer 
Document in 
Rs. Crore 
Amount 
received at 
the 
allotment 
of warrants 
in Rs. Crore 
Amount utilised in Rs. Crore 
Total 
unutilised 
amount in 
Rs. crore 
Comments of the 
Monitoring Agency 
Comments of the 
Board of Directors 
As at 
beginni
ng of 
the 
quarter 
in Rs. 
Crore 
During the 
quarter in 
Rs. Crore 
At the 
end of 
the 
quarter 
in Rs. 
Crore 
  
Reasons 
for idle 
funds 
Propose
d course 
of action 
1 
Investment (in the 
form of debt or 
equity) in Care 
Health Insurance 
Limited 
Chartered 
Accountant 
certificate*, Bank 
statements, 
Management 
certificate, 
Placement 
Document 
600.00 
375.00 
0.00 257.76 257.76 
39.25 
Out of total investment 
of Rs. 257.76 crore 
applied and deposited 
for investment in CHIL 
in Q2FY26, Rs. 256.10 
crore has been utilised 
against the share 
allotted as on 
September 30, 2025 
and balance amount of 
Rs. 1.65 crore 
refundable to REL is 
lying with CHIL as on 
September 30, 2025. 
The same has been 
received back in REL’s 
account in October 
2025. 
Nil Nil 
2 
Investment (in the 
form of debt or 
equity) in Religare 
Broking Limited 
Placement 
Document, 
Management 
certificate 
200.00 0.00 0.00 0.00 
No amount received 
and utilised towards 
this object in 
Q2FY2026. 
Nil Nil 
 
 CARE Ratings Limited  
9th floor, C-001/A2, Berger Towers, Sector 16B, 
Noida,  Gautam Budh Nagar, Uttar Pradesh -201301  
Phone: +91-120-4452000 
4th Floor, Godrej Coliseum, Somaiya Hospital 
Road, Off Eastern Express Highway, Sion (East), Mumbai - 400 022 
Phone: +91-22-6754 3456 
Email: care@careedge.in  •  www.careedge.in 
CIN-L67190MH1993PLC071691 
 
 
Sr. 
No 
Item 
Head 
Source of 
information / 
certifications 
considered by 
Monitoring 
Agency for 
preparation of 
report 
Amount as 
proposed 
in the Offer 
Document in 
Rs. Crore 
Amount 
received at 
the 
allotment 
of warrants 
in Rs. Crore 
Amount utilised in Rs. Crore 
Total 
unutilised 
amount in 
Rs. crore 
Comments of the 
Monitoring Agency 
Comments of the 
Board of Directors 
As at 
beginni
ng of 
the 
quarter 
in Rs. 
Crore 
During the 
quarter in 
Rs. Crore 
At the 
end of 
the 
quarter 
in Rs. 
Crore 
  
Reasons 
for idle 
funds 
Propose
d course 
of action 
3 
Investment (in the 
form of debt or 
equity) in Religare 
Housing 
Development 
Finance 
Corporation 
Limited 
Placement 
Document, 
Management 
certificate 
250.00 0.00 0.00 0.00 
No amount received 
and utilised towards 
this object in 
Q2FY2026. 
Nil Nil 
4 
Repayment of 
borrowings utilized 
and availed by the 
Company, together 
with interest 
payments accrued 
thereon 
Chartered 
Accountant 
certificate*, Bank 
statements, 
Management 
certificate, 
Placement 
Document 
75.00 0.00 75.00 75.00 
The funds received 
from issue proceeds to 
the tune of Rs. 75 crore 
were utilized towards 
repayments of loan to 
Religare Commodities 
Limited and JM 
Financial Product 
Limited, as per the 
objects of the issue. 
The amount has been 
debited from HDFC 
Current Account toward 
payment to these 2 
lenders. 
Nil Nil 
5 General Corporate 
Purpose 
Chartered 
Accountant 375.00 0.00 2.99 2.99 The funds have been 
used for repayment of Nil Nil 
 
 CARE Ratings Limited  
9th floor, C-001/A2, Berger Towers, Sector 16B, 
Noida,  Gautam Budh Nagar, Uttar Pradesh -201301  
Phone: +91-120-4452000 
4th Floor, Godrej Coliseum, Somaiya Hospital 
Road, Off Eastern Express Highway, Sion (East), Mumbai - 400 022 
Phone: +91-22-6754 3456 
Email: care@careedge.in  •  www.careedge.in 
CIN-L67190MH1993PLC071691 
 
 
Sr. 
No 
Item 
Head 
Source of 
information / 
certifications 
considered by 
Monitoring 
Agency for 
preparation of 
report 
Amount as 
proposed 
in the Offer 
Document in 
Rs. Crore 
Amount 
received at 
the 
allotment 
of warrants 
in Rs. Crore 
Amount utilised in Rs. Crore 
Total 
unutilised 
amount in 
Rs. crore 
Comments of the 
Monitoring Agency 
Comments of the 
Board of Directors 
As at 
beginni
ng of 
the 
quarter 
in Rs. 
Crore 
During the 
quarter in 
Rs. Crore 
At the 
end of 
the 
quarter 
in Rs. 
Crore 
  
Reasons 
for idle 
funds 
Propose
d course 
of action 
certificate*, Bank 
statements, Sample 
Invoices, 
Management 
certificate 
interest on loans, 
business expenses 
including salary 
payments and other 
vendor payments. 
Total 1500.00 375.00 0.00 335.75 335.75 39.25  
*Chartered Accountant certificates from J.C Bhalla & Co. Chartered Accountants dated November 12, 2025. 
 
(iii) Deployment of unutilized proceeds:  
 
Sr. No. 
Type of instrument and 
name of the entity invested 
in 
Amount invested Maturity date Earning Return on 
Investment (%) 
Market Value as at the 
end of quarter 
1 Axis Money Market Fund 30.00 Open 0.08 6.41% 30.08 
2 UTI Money Market Fund 9.25 Open 0.02 6.44% 9.27 
 Total 39.25  0.10  39.35 
 Less: Interest earned     0.10 
 Balance unutilized     39.25 
*Chartered Accountant certificates from J.C Bhalla & Co. Chartered Accountants dated November 12, 2025. 
  
 
 CARE Ratings Limited  
9th floor, C-001/A2, Berger Towers, Sector 16B, 
Noida,  Gautam Budh Nagar, Uttar Pradesh -201301  
Phone: +91-120-4452000 
4th Floor, Godrej Coliseum, Somaiya Hospital 
Road, Off Eastern Express Highway, Sion (East), Mumbai - 400 022 
Phone: +91-22-6754 3456 
Email: care@careedge.in  •  www.careedge.in 
CIN-L67190MH1993PLC071691 
 
 
 
(iv) Delay in implementation of the object(s) – 
Objects 
Completion Date Delay 
(no. of 
days/ 
months) 
Comments of the 
Board of Directors 
As per 
the offer 
document
Actual 
Reason 
of 
delay 
Proposed 
course of 
action 
Investment (in the form of debt or equity) in Care Health Insurance Limited 
Latest by 
March 11, 
2027 
Ongoing No Delay 
Nil Nil 
Investment (in the form of debt or equity) in Religare Broking Limited Nil Nil 
Investment (in the form of debt or equity) in Religare Housing Development Finance Corporation Limited Nil Nil 
Repayment of borrowings utilized and availed by the Company, together with interest payments accrued thereon Nil Nil 
General Corporate Purpose Nil Nil 
 
5) Details of utilization of proceeds stated as General Corporate Purpose (GCP) amount in the offer document: 
Sr. No Item Head^ Amount 
in Rs. Crore Source of information / certifications 
considered by Monitoring Agency for 
preparation of report 
Comments of Monitoring 
Agency 
Comments of the Board of 
Directors 
1 
Interest paid on loan 
taken from JM Financial 
Product Limited 
0.22 
Chartered Accountant certificate*, Bank 
statements, Management certificate, 
Placement Document 
The company has paid Rs. 0.22 crore 
towards interest on loan to JM 
Financial Product Limited. The same 
amount is debited from HDFC 
Current Account  statement.  
NA 2 
Interest on Loan from 
Religare Commodities 
Limited 
1.30 
Chartered Accountant certificate*, Bank 
statements, Management certificate, 
Placement Document, CTC of Board 
resolution approving the expense approval 
matrix  
The company has paid Rs. 1.29 
crore towards interest on loan to 
Religare Commodities Limited. The 
same amount is debited from HDFC 
Current Account statement. 
3 Payment of Operating 
expense 1.47 
Chartered Accountant certificate*, Bank 
statements, Invoices, Management 
certificate, Placement Document, CTC of 
Board resolution approving the expense 
approval matrix 
The company has incurred expenses 
of Rs. 1.37 crore towards various 
operating expenses including 
salaries, issue related expenses and 
other administrative vendor 
payments. The same amount is 
 
 CARE Ratings Limited  
9th floor, C-001/A2, Berger Towers, Sector 16B, 
Noida,  Gautam Budh Nagar, Uttar Pradesh -201301  
Phone: +91-120-4452000 
4th Floor, Godrej Coliseum, Somaiya Hospital 
Road, Off Eastern Express Highway, Sion (East), Mumbai - 400 022 
Phone: +91-22-6754 3456 
Email: care@careedge.in  •  www.careedge.in 
CIN-L67190MH1993PLC071691 
 
 
Sr. No Item Head^ Amount 
in Rs. Crore Source of information / certifications 
considered by Monitoring Agency for 
preparation of report 
Comments of Monitoring 
Agency 
Comments of the Board of 
Directors 
debited from HDFC Current Account 
statement. 
 Total 2.99    
*Chartered Accountant certificates from J.C Bhalla & Co. Chartered Accountants dated November 12, 2025. 
 
^ Section from the offer document related to GCP: 
 “Up to 25% (twenty five percent) of the Issue Proceeds will be utilised for general corporate purposes, which includes, inter alia, meeting ongoing general corporate exigencies 
and contingencies, expenses of the Company as applicable in such a manner and proportion as may be decided by the Board from time to time, and/or any other general 
purposes as may be permissible under applicable laws.” 
 
 CARE Ratings Limited  
9th floor, C-001/A2, Berger Towers, Sector 16B, 
Noida,  
Gautam Budh Nagar, Uttar Pradesh -201301  
Phone: +91-120-4452000 
4th Floor, Godrej Coliseum, Somaiya Hospital 
Road, Off Eastern Express Highway, Sion (East), 
Mumbai - 400 022 
Phone: +91-22-6754 3456 
Email: care@careedge.in  •  www.careedge.in 
CIN-L67190MH1993PLC071691 
 
 
 
Disclaimers to MA report:  
 
a) This Report is prepared by CARE Ratings Ltd (hereinafter referred to as “Monitoring Agency/MA”). The MA has 
taken utmost care to ensure accuracy and objectivity while developing this Report based on the information 
provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The views 
and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any 
manner whatsoever.  
b) This Report has to be seen in its entirety; the selective review of portions of the Report may lead to inaccurate 
assessments. For the purpose of this Report, MA has relied upon the information provided by the management 
/officials/ consultants of the Issuer and third-party sources like statutory auditor which is peer reviewed audit 
firm/peer reviewed audit firm appointed by the Issuer believed by it to be accurate and reliable.  
c) Nothing contained in this Report is capable or intended to create any legally binding obligations on the MA which 
accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The MA is also not 
responsible for any errors in transmission and specifically states that it, or its directors, employees do not have any 
financial liabilities whatsoever to the users of this Report.  
d) The MA and its affiliates do not act as a fiduciary. The MA and its affiliates also do not act as an expert to the 
extent defined under Section 2(38) of the Companies Act, 2013. While the MA has obtained information from 
sources it believes to be reliable, it does not perform an audit and undertakes no independent verification of any 
information/ certifications/ statements it receives from statutory auditors which is peer reviewed audit firm, 
lawyers, chartered engineers or other experts, and relies on in its reports.  
e) The MA or its affiliates may have other commercial transactions with the entity to which the report pertains. 
As an example, the MA may rate the issuer or any debt instruments / facilities issued or proposed to be issued 
by the issuer that is subject matter of this report. The MA may receive separate compensation for its ratings and 
certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or 
from obligors. 
 
 
 
 
